Novel tests for latent infection have been developed based on the measurement of gamma-interferon (IFN-γ) production from peripheral blood mononuclear cells in response to two M. tuberculosis secreted proteins, ESAT-6 and CFP-10, absent in the vaccine strain BCG [7,8]. This evidence concerns the gene IFNG and disease arising from reactivation of latent virus.